Drug Selection and Patient Matching

Drug selection and patient matching is the reasoning by which a clinician or pharmacist chooses, from the available therapeutic options, the medicine and formulation best suited to a particular patient and indication. It moves beyond asking whether a drug is effective in general to asking whether it is the right drug for this patient, given their diagnosis, comorbidities, other medicines, organ function, preferences, and the strength of the supporting evidence.

Definition

Drug selection and patient matching is the structured process of choosing among therapeutic options and aligning the choice with an individual patient's diagnosis, characteristics, comedications, and preferences, weighing expected benefit against risk and the available evidence.

Scope

The topic covers the components of rational drug choice: defining the therapeutic goal, comparing options on efficacy and safety, accounting for patient-specific factors and contraindications, and recognising when a drug is potentially inappropriate. It treats selection as a structured reasoning process and as a reference topic, not as a set of prescribing recommendations.

Core questions

• What is the therapeutic goal, and which drug classes can meet it?
• Which patient factors (organ function, age, comorbidity, genetics, preferences) constrain the choice?
• How do concurrent medicines and diseases make a given drug more or less appropriate?
• When is a drug potentially inappropriate, and what tools help recognise this?
• How is the benefit-risk balance weighed for this patient rather than a population?

Key concepts

• Rational drug use
• Therapeutic goal definition
• Benefit-risk balancing
• Contraindications and cautions
• Patient-specific factors
• Potentially inappropriate prescribing
• Explicit and implicit prescribing criteria
• Deprescribing

Mechanisms

Matching a drug to a patient combines pharmacological reasoning with patient assessment. The expected effect of a drug depends on pharmacokinetic and pharmacodynamic factors that vary between patients, so the same nominal choice carries different benefit and risk in different people. Selection therefore integrates the indication, the comparative evidence for candidate drugs, the patient's organ function, age, comorbidities, genetics, and current medicines, and any contraindications. Tools such as explicit appropriateness criteria translate this reasoning into checkable rules, helping flag drugs that should usually be avoided or started in defined patient groups.

Clinical relevance

Sound drug selection is central to safe and effective medicine use and is a core competency of clinical pharmacy. As a reference topic it explains the structure of selection reasoning and the role of appropriateness criteria; it describes how choices are framed and does not constitute prescribing, dosing, or individualised treatment advice.

Epidemiology

The need for careful matching grows with multimorbidity and polypharmacy: many patients, especially older adults, live with several conditions and take multiple medicines simultaneously, which raises the risk of inappropriate choices. Adverse drug reactions arising in part from suboptimal selection account for a measurable share of hospital admissions.

Evidence & guidelines

Selection is informed by comparative effectiveness evidence for specific drug classes and by explicit prescribing-appropriateness instruments such as the STOPP/START criteria, which list drugs that are potentially inappropriate or under-used in older people. These tools complement, rather than replace, individualised clinical judgement.

History

Prescribing evolved from largely empirical drug choice toward evidence-based and appropriateness-guided selection as controlled trials and pharmacokinetic understanding matured in the later twentieth century. The recognition of widespread polypharmacy and inappropriate prescribing in ageing populations prompted the development of explicit criteria to support more systematic matching of drugs to patients.

Debates

Explicit criteria versus individualised judgement

Explicit tools such as STOPP/START make inappropriate prescribing checkable and reproducible, but critics note they cannot capture every patient context; the balance between rule-based screening and case-by-case clinical reasoning remains an active discussion.

Seminal works

• omahony-2014
• wilkinson-2005

Frequently asked questions

What does it mean to match a drug to a patient?

It means choosing among effective options the one whose benefit-risk profile best fits the individual's diagnosis, organ function, comorbidities, other medicines, and preferences, rather than applying a one-size-fits-all choice.

What are STOPP/START criteria?

They are explicit lists used as a reference to flag medicines that are potentially inappropriate (STOPP) or that may be under-used (START) in older people, supporting more systematic review of drug choices.